Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

High Rates of Venous and Arterial Thrombotic Events in POEMS Patients: Results from the UK-Based POEMS Registry, Highlighting the Need for Therapeutic Guidelines

Zara Sayar, MD FRCPath, MRCP, Anna Weatherill, Stephen Keddie, Jonathan Sive, MD, Michael P Lunn, Mari Thomas, Shirley D'Sa

Blood (2019) 134 (Supplement_1): 714.

https://doi.org/10.1182/blood-2019-125639

Published: 2019

Journal Articles

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation

Ljupco Veskovski, MD, Per-Ola Andersson, MD PhD, Ingemar Turesson, MD PhD, Daniel Malmodin, PhD, Anders Pedersen, PhD, Ulf-Henrik Mellqvist, MD PhD

Blood (2019) 134 (Supplement_1): 1771.

https://doi.org/10.1182/blood-2019-121961

Published: 2019

Journal Articles

Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban

Damon E. Houghton, MDMS, Jordan Cochuyt, David O. Hodge, MS, Danielle Vlazny, PA-C, Ana I Casanegra, MD, Lisa Peterson, RN, David A Froehling, MD, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD

Blood (2019) 134 (Supplement_1): 2158.

https://doi.org/10.1182/blood-2019-125099

Published: 2019

Journal Articles

The Development of Ironchild: A Web-Based Intervention to Improve Adherence in Children with Iron Deficiency Anemia

Jacquelyn M. Powers, MD,MSc, Deborah I Thompson, PhD

Blood (2019) 134 (Supplement_1): 2163.

https://doi.org/10.1182/blood-2019-124181

Published: 2019

Journal Articles

Development of a Low-Cost Electrical Impedance-Based Microflow Cytometer

Darryl Dieujuste, BS,MS, Jia Liu, E. Du, PhD, Ofelia A. Alvarez, MD

Blood (2019) 134 (Supplement_1): 4665.

https://doi.org/10.1182/blood-2019-129068

Published: 2019

Journal Articles

Whole Exome Sequencing of Relapsed Double-Mutated CEBPA Acute Myeloid Leukemia Identified Mutated KIT and WNT10A As a Potential Co-Mutation with Negative Impact on Prognosis

Chin-Hin NG, MD MRCP, FRCPATH, MCI, Alvin Yu-Jin Ng, PhD, Benedict Yan, MBBS, Wee-Joo Chng, MBBS, PhD

Blood (2019) 134 (Supplement_1): 5177.

https://doi.org/10.1182/blood-2019-127727

Published: 2019

Journal Articles

High-Throughput RNA Sequencing Analysis Reveals Distinct Molecular Signature in NRAS and PTPN11 JMML Patients

Pier Paolo Leoncini, PhD, Alessandro Domenico Silvestris, PhD, Patrizia Vitullo, PhD, Marco Zecca, MD, Christian Flotho, MD PhD, Charlotte M. Niemeyer, MD, Angela Gallo, PhD, Alice Bertaina, MD PhD, Franco Locatelli, MD PhD, Pietro Merli, MD

Blood (2019) 134 (Supplement_1): 4229.

https://doi.org/10.1182/blood-2019-129965

Published: 2019

Journal Articles

Mechanical Loading Shows Anti-Myeloma Effects While Rescuing Bone Loss with Net Bone Formation in a Myeloma Bone Disease Murine Model

Fani Ziouti, Maximilian Rummler, Andreas Brandl, PhD, Andreas Beilhack, MD, Maureen Lynch, PhD, Bettina Willie, PhD, Franziska Jundt, MD

Blood (2018) 132 (Supplement 1): 3164.

https://doi.org/10.1182/blood-2018-99-116796

Published: 2018

Journal Articles

Deregulated Expression of Circular RNAs in Acute Myeloid Leukemia

Susanne Lux, MSc, Tamara J. Blätte, MSc, Sibylle Cocciardi, MSc, Klaus Schwarz, MD, Hartmut Döhner, MD, Konstanze Döhner, MD, Lars Bullinger, MD, Anna Dolnik, PhD

Blood (2018) 132 (Supplement 1): 3894.

https://doi.org/10.1182/blood-2018-99-113333

Published: 2018

Journal Articles

A Genetic Variant in GOLGB1 Affects Golgi Function and Stroke Risk in Patients with Sickle Cell Disease

Varshika Kotu, PhD, Julien Dubrelle, PhD, Jasmine Baker, PhD, Katherine Jenson, Bsc, Jonathan M. Flanagan, PhD

Blood (2018) 132 (Supplement 1): 3649.

https://doi.org/10.1182/blood-2018-99-119605

Published: 2018

Journal Articles

Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin

Damon E. Houghton, MD, Dalene M. Bott-Kitslaar, APRN, CNP, Emily Vargas, MPH, David O. Hodge, MS, Teresa R Lang, PA-C, Lisa Peterson, RN, Ana I Casanegra, MD, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD, David A Froehling, MD

Blood (2018) 132 (Supplement 1): 362.

https://doi.org/10.1182/blood-2018-99-114185

Published: 2018

Journal Articles

Prognostic Testing and Treatment Approaches in Patients with Chronic Lymphocytic Leukemia: Clinical Experience from an Interim Analysis of the informCLL TM Real-World Registry

Anthony R. Mato, MDMSCE, Jacqueline C. Barrientos, MD MS, Danielle M. Brander, MD, John M. Pagel, MD PhD, Meghan Gutierrez, Karen Kadish, MSN, Brian Tomlinson, MPA, Nilanjan Ghosh, MD PhD, Nick Giafis, PhD, David Ipe, Sandhya Upasani, Murali Sundaram, MBA, PhD, Lucille Ferrante, MD, Carlos Amaya-Chanaga, MD, Reethi Iyengar, PhD, Jeff Sharman, MD

Blood (2018) 132 (Supplement 1): 4425.

https://doi.org/10.1182/blood-2018-99-110566

Published: 2018

Journal Articles

Mutational Phasing: Clinical Relevance in Tyrosine Kinase Domain Mutations Using Next Generation Sequencing in Chronic Myeloid Leukemia

Seema S. Bhatwadekar, MD, Parth Shah, MD

Blood (2018) 132 (Supplement 1): 4269.

https://doi.org/10.1182/blood-2018-99-114130

Published: 2018

Journal Articles

Genomic and Immune Profiles of Multiple Myeloma Revealed By Whole Genome and Transcriptome Sequencing

Christopher J. Yoon, MPhil, Hyojin Song, Seulki Song, Hyejoo Park, Dong-Yeop Shin, MD PhD, Junshik Hong, MD, Inho Kim, MD PhD, Hyun Jung Lee, MD, Byung-Su Kim, MD PhD, Jung Lim Lee, MD, Sung-Soo Yoon, MD PhD, Young Seok Ju, Youngil Koh, MD PhD

Blood (2018) 132 (Supplement 1): 4493.

https://doi.org/10.1182/blood-2018-99-117546

Published: 2018

Journal Articles

HLA Class II Epitope Mismatch Influences Relapse and Engraftment in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation

Joseph Rimando, MD, Michael Slade, MD MS, Feng Gao, PhD, Rizwan Romee, MD, Chang Liu, MD PhD

Blood (2018) 132 (Supplement 1): 4634.

https://doi.org/10.1182/blood-2018-99-112494

Published: 2018

Journal Articles

Emerging Real-World Midostaurin Treatment Patterns and Outcomes in FLT3-Mutated Acute Myeloid Leukemia at a Comprehensive Cancer Center

Connor Willis, PharmD, Jyothi Menon, PhD, Sudhir Unni, PhD, Trang Au, PharmD, Briana Ndife, MPH, George J Joseph, BPharm, MS, PhD, Gaetano J Bonifacio, MD, Eytan M. Stein, MD, Srinivas K. Tantravahi, MBBS, Paul J Shami, MD, Tibor Kovacsovics, MD, Diana Brixner, PhD, David Dean Stenehjem, PharmD

Blood (2018) 132 (Supplement 1): 4745.

https://doi.org/10.1182/blood-2018-99-115009

Published: 2018

Journal Articles

Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center

Minkyoung Yoo, Jyothi Menon, PhD, Connor Willis, PharmD, Sudhir Unni, PhD, Trang Au, PharmD, Joseph Biskupiak, PhD, Briana Ndife, MPH, George J Joseph, BPharm, MS, PhD, Gaetano J Bonifacio, MD, Eytan M. Stein, MD, Srinivas K. Tantravahi, MBBS, Paul J. Shami, MD, Tibor Kovacsovics, MD, Diana Brixner, PhD, David Dean Stenehjem, PharmD

Blood (2018) 132 (Supplement 1): 5857.

https://doi.org/10.1182/blood-2018-99-113479

Published: 2018

Journal Articles

Comparison of Healthcare Resource Utilization and Costs Related to Infections between Patients Newly Diagnosed with Chronic Myeloid Leukemia Treated with Dasatinib and Nilotinib As First-Line Therapy in the United States

Karen Seiter, MD, Dominick Latremouille-Viau, Annie Guerin, MS, Briana Ndife, MPH, Karen Habucky, PhD, George J Joseph, BPharm, MS, PhD, Irina Pivneva, PhD, Patrick Gagnon-Sanschagrin, MS, Derek H Tang, BSPharm, PhD

Blood (2017) 130 (Supplement 1): 3391.

https://doi.org/10.1182/blood.V130.Suppl_1.3391.3391

Published: 2017

Journal Articles

Treatment Patterns in Patients with Chronic Myeloid Leukemia in Chronic Phase in US Clinical Practice, with a Focus on Tyrosine Kinase Inhibitor Therapy Discontinuation

Ellen K Ritchie, MD, Dominick Latremouille-Viau, Annie Guerin, MS, Irina Pivneva, PhD, Karen Habucky, PhD, Briana Ndife, MPH, George J Joseph, BPharm, MS, PhD, Ehab Atallah, MD

Blood (2017) 130 (Supplement 1): 3396.

https://doi.org/10.1182/blood.V130.Suppl_1.3396.3396

Published: 2017

Journal Articles

Disease and Treatment Knowledge Deficits in Patients with Mild and Moderate Hemophilia May Impact Transition Readiness

Amy L. Dunn, MD, Linda Casto, MSW, LSIW, Pamela Widener, RN, BSN, Charmaine Biega, RN, Joseph R Stanek, MS

Blood (2017) 130 (Supplement 1): 5636.

https://doi.org/10.1182/blood.V130.Suppl_1.5636.5636

Published: 2017

NARROW

High Rates of Venous and Arterial Thrombotic Events in POEMS Patients: Results from the UK-Based POEMS Registry, Highlighting the Need for Therapeutic Guidelines

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation

Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban

The Development of Ironchild: A Web-Based Intervention to Improve Adherence in Children with Iron Deficiency Anemia

Development of a Low-Cost Electrical Impedance-Based Microflow Cytometer

Whole Exome Sequencing of Relapsed Double-Mutated CEBPA Acute Myeloid Leukemia Identified Mutated KIT and WNT10A As a Potential Co-Mutation with Negative Impact on Prognosis

High-Throughput RNA Sequencing Analysis Reveals Distinct Molecular Signature in NRAS and PTPN11 JMML Patients

Mechanical Loading Shows Anti-Myeloma Effects While Rescuing Bone Loss with Net Bone Formation in a Myeloma Bone Disease Murine Model

Deregulated Expression of Circular RNAs in Acute Myeloid Leukemia

A Genetic Variant in GOLGB1 Affects Golgi Function and Stroke Risk in Patients with Sickle Cell Disease

Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin

Prognostic Testing and Treatment Approaches in Patients with Chronic Lymphocytic Leukemia: Clinical Experience from an Interim Analysis of the informCLL TM Real-World Registry

Mutational Phasing: Clinical Relevance in Tyrosine Kinase Domain Mutations Using Next Generation Sequencing in Chronic Myeloid Leukemia

Genomic and Immune Profiles of Multiple Myeloma Revealed By Whole Genome and Transcriptome Sequencing

HLA Class II Epitope Mismatch Influences Relapse and Engraftment in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation

Emerging Real-World Midostaurin Treatment Patterns and Outcomes in FLT3-Mutated Acute Myeloid Leukemia at a Comprehensive Cancer Center

Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center

Comparison of Healthcare Resource Utilization and Costs Related to Infections between Patients Newly Diagnosed with Chronic Myeloid Leukemia Treated with Dasatinib and Nilotinib As First-Line Therapy in the United States

Treatment Patterns in Patients with Chronic Myeloid Leukemia in Chronic Phase in US Clinical Practice, with a Focus on Tyrosine Kinase Inhibitor Therapy Discontinuation

Disease and Treatment Knowledge Deficits in Patients with Mild and Moderate Hemophilia May Impact Transition Readiness

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only